SAN DIEGO, May 19, 2016 —Edico Genome, creator of the world’s first bio-IT processor designed to analyze next-generation sequencing (NGS) data, today announced a third, foundational patent issued by the United States Patent and Trademark Office. U.S. patent number 14/948372, entitled “Bioinformatics Systems, Apparatuses, And Methods Executed On An Integrated Circuit Processing Platform,” broadly covers the technology and methods of use that are core to the DRAGEN™ Bio-IT Processor, including the hardware processing platform and its use for executing a sequence analysis pipeline on genomic data for both onsite and cloud deployment. The patent will provide protection until 2032.
“The innovation of our DRAGEN Bio-IT Processor is reflected in our growing patent estate and, most importantly, brisk customer adoption seen in our first year of commercialization,” said Pieter van Rooyen, Ph.D., chief executive officer of Edico Genome. “Our IP position provides customers as well as collaborators assurance that they’re engaging with best-in-class genomic data analysis technologies and can confidently explore with us additional applications and partnerships that leverage DRAGEN’s unique data-crunching capabilities for onsite and cloud deployment. Our solution provides the most efficient and cost-effective way to analyze genomic data.”
The DRAGEN ultra-rapid bioinformatics processor accelerates the secondary analysis of NGS data, reducing the time required for analyzing a genome at 30x coverage from hours to minutes. DRAGEN uses a field-programmable gate array (FPGA) to implement genome pipeline algorithms, including BCL conversion, compression, mapping, alignment, sorting, duplicate marking and haplotype variant calling. Pipelines available on the DRAGEN platform include Whole Genome or Exome, Transcriptome/RNAseq, Metagenome/Microbiome, Epigenome/Methylome and Joint Genotyping. The highly reconfigurable DRAGEN platform allows for custom algorithm development as well as refinement and improvement of existing pipelines.
About Edico Genome
Edico Genome has created the world’s first bioinformatics processor designed to analyze next-generation sequencing data, DRAGEN™. The use of next-generation sequencing is growing at an unprecedented pace, creating a need for a technology that can process this big data rapidly and accurately. Edico Genome’s computing platform has been shown to speed whole genome data analysis from hours to minutes, while maintaining high accuracy and reducing costs, enabling clinicians and researchers to reveal answers more quickly. For more information, visit www.EdicoGenome.com or follow @EdicoGenome.